Clive Pritchard

• AIDS/HIV
• Infectious Diseases
• TB
• Drug Development/R&D
• Emerging Markets
• Real World Evidence (RWE)

Donor Investment Choices: Modeling the Value for Money of Investing in Product Development, Public Private Parnerships as Compared to Other Health Care and Non-Health Care Interventions

Read more

• NHS
• NICE
• Review
• UK

Developments in Economic Evaluation in Health Care: A Review of HEED

Read more

• Review

To Heal and Harm: An Economic View of Drug Safety

Read more

• Cost-Effectiveness Thresholds
• Economic Evaluation

Cost-Effectiveness Thresholds: Economic and ethical issues

Read more

• Real World Evidence (RWE)

Capturing the Unexpected Benefits of Medical Research

Read more